270 related articles for article (PubMed ID: 22039318)
21. Association of serum adipocytokines with insulin resistance and liver injury in patients with chronic hepatitis C genotype 4.
Khattab MA; Eslam M; Aly MM; Shatat M; Hussen A; Moussa YI; Elsaghir G; Abdalhalim H; Aly A; Gaber S; Harrison SA
J Clin Gastroenterol; 2012; 46(10):871-9. PubMed ID: 22664476
[TBL] [Abstract][Full Text] [Related]
22. Virus-induced over-expression of protein phosphatase 2A inhibits insulin signalling in chronic hepatitis C.
Bernsmeier C; Duong FH; Christen V; Pugnale P; Negro F; Terracciano L; Heim MH
J Hepatol; 2008 Sep; 49(3):429-40. PubMed ID: 18486982
[TBL] [Abstract][Full Text] [Related]
23. Transforming Growth Factor β Acts as a Regulatory Molecule for Lipogenic Pathways among Hepatitis C Virus Genotype-Specific Infections.
Patra T; Sasaki R; Meyer K; Ray RB; Ray R
J Virol; 2019 Sep; 93(18):. PubMed ID: 31243135
[TBL] [Abstract][Full Text] [Related]
24. Metabolic Manifestations of Hepatitis C Virus: Diabetes Mellitus, Dyslipidemia.
Serfaty L
Clin Liver Dis; 2017 Aug; 21(3):475-486. PubMed ID: 28689587
[TBL] [Abstract][Full Text] [Related]
25. [Clinical correlations of chronic hepatitis C, diabetes mellitus and steatohepatitis].
Nemesánszky E
Orv Hetil; 2011 May; 152(22):882-6. PubMed ID: 21565756
[TBL] [Abstract][Full Text] [Related]
26. Insulin resistance and steatosis in chronic hepatitis C.
Machado MV; Cortez-Pinto H
Ann Hepatol; 2009; 8 Suppl 1():S67-75. PubMed ID: 19381127
[TBL] [Abstract][Full Text] [Related]
27. Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection.
Petta S; Cammà C; Di Marco V; Alessi N; Cabibi D; Caldarella R; Licata A; Massenti F; Tarantino G; Marchesini G; Craxì A
Am J Gastroenterol; 2008 May; 103(5):1136-44. PubMed ID: 18477344
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis C virus and type 2 diabetes.
Negro F; Alaei M
World J Gastroenterol; 2009 Apr; 15(13):1537-47. PubMed ID: 19340895
[TBL] [Abstract][Full Text] [Related]
29. Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C.
Fartoux L; Poujol-Robert A; Guéchot J; Wendum D; Poupon R; Serfaty L
Gut; 2005 Jul; 54(7):1003-8. PubMed ID: 15951550
[TBL] [Abstract][Full Text] [Related]
30. Genotype-specific interactions of insulin resistance, steatosis, and fibrosis in chronic hepatitis C.
Cua IH; Hui JM; Kench JG; George J
Hepatology; 2008 Sep; 48(3):723-31. PubMed ID: 18688878
[TBL] [Abstract][Full Text] [Related]
31. Role of insulin resistance and hepatic steatosis in the progression of fibrosis and response to treatment in hepatitis C.
Sanyal AJ
Liver Int; 2011 Jan; 31 Suppl 1():23-8. PubMed ID: 21205134
[TBL] [Abstract][Full Text] [Related]
32. Insulin resistance in chronic hepatitis B and C.
Mohammad Alizadeh AH; Fallahian F; Alavian SM; Ranjbar M; Hedayati M; Rahimi F; Khedmat H; Etemadi A; Zali MR; Azizi F
Indian J Gastroenterol; 2006; 25(6):286-9. PubMed ID: 17264427
[TBL] [Abstract][Full Text] [Related]
33. Steatosis in chronic hepatitis C: why does it really matter?
Asselah T; Rubbia-Brandt L; Marcellin P; Negro F
Gut; 2006 Jan; 55(1):123-30. PubMed ID: 16344578
[TBL] [Abstract][Full Text] [Related]
34. [Insulin resistance in chronic hepatitits C].
Parise ER; Oliveira AC
Arq Gastroenterol; 2007; 44(2):178-84. PubMed ID: 17962866
[TBL] [Abstract][Full Text] [Related]
35. Serum HCV RNA levels correlate with histological liver damage and concur with steatosis in progression of chronic hepatitis C.
Adinolfi LE; Utili R; Andreana A; Tripodi MF; Marracino M; Gambardella M; Giordano M; Ruggiero G
Dig Dis Sci; 2001 Aug; 46(8):1677-83. PubMed ID: 11508667
[TBL] [Abstract][Full Text] [Related]
36. Systematic review: chronic viral hepatitis and metabolic derangement.
Wang CC; Cheng PN; Kao JH
Aliment Pharmacol Ther; 2020 Jan; 51(2):216-230. PubMed ID: 31746482
[TBL] [Abstract][Full Text] [Related]
37. The impact of obesity and metabolic syndrome on chronic hepatitis C.
Goossens N; Negro F
Clin Liver Dis; 2014 Feb; 18(1):147-56. PubMed ID: 24274870
[TBL] [Abstract][Full Text] [Related]
38. Morphological changes in intracellular lipid droplets induced by different hepatitis C virus genotype core sequences and relationship with steatosis.
Piodi A; Chouteau P; Lerat H; Hézode C; Pawlotsky JM
Hepatology; 2008 Jul; 48(1):16-27. PubMed ID: 18570290
[TBL] [Abstract][Full Text] [Related]
39. Hepatitis C and steatosis.
Björnsson E; Angulo P
Arch Med Res; 2007 Aug; 38(6):621-7. PubMed ID: 17613353
[TBL] [Abstract][Full Text] [Related]
40. Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C.
Miquilena-Colina ME; Lima-Cabello E; Sánchez-Campos S; García-Mediavilla MV; Fernández-Bermejo M; Lozano-Rodríguez T; Vargas-Castrillón J; Buqué X; Ochoa B; Aspichueta P; González-Gallego J; García-Monzón C
Gut; 2011 Oct; 60(10):1394-402. PubMed ID: 21270117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
